Alaunos Therapeutics (TCRT)

• Market cap: $3.78M
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.

Employees: 34

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

2,167% more call options, than puts

Call options by funds: $68K | Put options by funds: $3K

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

11% more funds holding

Funds holding: 46 [Q1] → 51 (+5) [Q2]

0.43% more ownership

Funds ownership: 14.75% [Q1] → 15.18% (+0.43%) [Q2]

58% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 12

60% less capital invested

Capital invested by funds: $4.26M [Q1] → $1.71M (-$2.56M) [Q2]